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Abstract 
Lipid peroxidation (LPO) is a causative factor of cataract. The increased concentrations of primary molecular LPO products (diene 
conjugates, lipid hydroperoxides) and end fluorescent LPO products, were detected in the lipid moieties of the aqueous humor samples 
obtained from patients with senile and complicated cataracts as compared to normal donors. The degrees of lens clouding were assessed 
quantitatively b  measuring the optical density indices and areas of equidensities u ing digital image analysis. Human cataractous lenses 
showed decreased activity of glutathione peroxidase (GPX, catalyzing reduction of organic hydroperoxides including hydroperoxides of 
lipids). The apparent K m for tert-butylhydroperoxide was 0.434 mM for human normal and cataractous lens GPX. When lenses were 
exposed for 1 h at 37°C to linoleic acid hydroperoxide (LOOH, 0.5 mM) or egg phosphatidyl-choline hydroperoxide (PLOOH, 1 /xmol 
per 112 #mol of phospholipid) in liposomes uspended in the incubation medium, normal, immature and mature human cataractous 
lenses showed a significant loss in the residual content of liberated LOOH to 62%, 38% or 17%, correspondingly, but little or no 
reduction was observed with PLOOH in liposomal membranes. Human, rabbit or mice transparent or immature cataractous lenses induced 
significantly more absorbance changes in conjugated diene, iodometric and TBA-reactive substance measurements when incubated with 
liposomal membranes which were decreased in the presence of free radical scavengers and antioxidant enzymes (EDTA, SOD, 
L-carnosine, chelated iron, catalase). Injection into the vitreous body of the rabbit eye of a suspension of liposomes prepared from 
phospholipids containing LPO products induced the development of posterior subcapsular cataract. Saturated liposomes did not cause 
clouding of the lens. This modelling of cataract was accompanied by accumulation of fluorescing LPO products in the vitreous body, 
aqueous humor and the lens and also by a fall in the concentration of GSH in the lens. The peroxidative damage to the lens cell 
membranes and biomolecules induced in the lack of reductive detoxification of phospholipid hydroperoxides is proposed as the triggering 
mechanism of cataractogenesis. 
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1. Introduction 
It is well established that a major factor involved in the 
development of cataract is oxidative insult [1-12]. Oxida- 
tive stress associated with the formation of lipid peroxides 
is suggested to contribute to pathological processes in 
ageing and systemic diseases, such as diabetes, athero- 
sclerosis, chronic renal failure, inflammation and retinal 
degenerative diseases known as statistically significant risk 
factors for cataract [13-18]. The observation that lipid 
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peroxides are elevated in the lens membranes of some 
patients with cataract has drawn attention to these toxic 
oxidants [19-21]. Lipid peroxides can cause cataract, pro- 
ducing damages to both cell membrane and cytosol regions 
[18,20,22-26]. At the membrane, lipid hydroperoxides in- 
duce changes in permeability [27-30], refashion the micro- 
viscosity (order) of its lipid-protein environment [31-33], 
cause an uncoupling of the membrane-bound enzyme Na, 
K-ATPase and oxidative inhibition of Ca2+-ATPase in 
several tissues including the lens [34-36]. Within the cell, 
lipid peroxides can damage DNA [37], induce a drop in 
total glutathione and dramatic hange in the redox ratio of 
glutathione, lead to the appearance of new fluorophores 
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and large protein aggregates with low solubility (clouding 
matrix) in the lens matter [12,37-41]. 
The aqueous humor contains about 4 /xg/ml of high 
density lipoproteins, which evidently take part in the re- 
newal of lipid compositions of the lens [42,43]. The oxida- 
tive modification of lipoproteins in the presence of trace 
amounts of transition metals (copper or iron) is variously 
associated with lipid peroxidation (LPO), an increase in 
net negative charge, hydrolysis of phospholipid and frag- 
mentation of apoprotein B (for review see Ref. [44]) and 
the oxidized lipid moieties of lipoprotein particles can be 
implicated to the lens toxicity triggering cataractogenesis 
[45,46]. Supposedly, this event is controlled because of the 
ability of reduced glutathione (GSH) of the lens to detox- 
ify hydroperoxides via glutathione peroxidase (GPX) 
[47,48]. The enzymatic detoxification of lipid-derived hy- 
droperoxides in which GSH-dependent selenoperoxidase 
of the lens is thought to play a key role, leads to reduction 
of hydroperoxides (LOOH) to alcohols at the expense of 
GSH (Eq. 1) which regeneration to the reduced form is 
catalyzed by GSSG reductase (Eq. 2), utilizing NADPH as 
a co-factor [49,50]: 
LOOH + 2 GSH ~ LOH + GSSG + H 2 0 (1) 
NADPH + H + + GSSG ~ NADP + + 2GSH (2) 
Studies with phospholipid membrane vesicles (liposomes) 
which lacked cholesterol and lipoproteins have indicated 
that classical GPX does not act directly on phospholipid 
hydroperoxides ither membrane-bound or detergent-dis- 
persed [51]. The phospholipid hydroperoxides present in 
the human erythrocyte ghost natural membrane rich in 
cholesterol comparably to the lens membranes [52], are 
also unreactive with GPX unless first hydrolyzed by phos- 
pholipase A 2 [53]. At last, cholesterol hydroperoxides 
were found to be totally resistant o GPX, even after 
extraction from the membrane [53]. These findings raised 
an important question of how the lens might detoxify 
phospholipid hydroperoxides which mediate oxidative 
stress implicated in development of maturity onset cataract. 
The ability of the lens to catalyze directly in situ reduction 
of phospholipid hydroperoxides in model membranes and 
the lens GPX ability to remove certain organic (including 
liberated fatty acid) hydroperoxides were quested in this 
study. 
2. Materials and methods 
2.1. Patients 
Aqueous humor and human lenses were obtained from 
patients undergoing intracapsular c yoextraction of senile 
or complicated cataracts and used as the test material. This 
project was approved by the ethic commission of Helmholtz 
Research Institute for Eye Diseases (no. 008/136/30). 
The control aqueous and transparent human lenses were 
obtained from eyes donated for corneal grafting supplied 
from a corneal transplant bank within 15 h post mortem. 
The mean age at surgery and the average donor age was 59 
years ranging from 16 to 89 years. Both groups contained 
an almost equal number of males and females. 
2.2. Aqueous humor sampling 
After retrobulbar and l, id anesthesia the two vertical 
recti muscles were fixed. A stab incision was performed 
transcorneally 1 mm from the limbus in the temporal 
superior quadrant. Aqueous humor from human eyes (about 
0.1-0.2 ml per eye) was aspirated from the anterior cham- 
ber of each eye with a 25-gauge needle connected to a 
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Fig. 1. Image analysis procedure which makes it possible to obtain an image of the lens, to determine values of the optical density in different parts of the 
lens, to divide the lens surface into zones of defined ensity range, to measure the areas of equidensities and to evaluate the precise topography of every 
zone. All parameters are estimated quantitatively by use of a computer. The lens is illuminated in a frontal projection, adjusting the intensity of the 
illuminating light to make the transmission through each lens constant. An electronically produced measuring field is determined by a circular mask whose 
position is under the control of the analyser. To control its position, the coordinates of the central point of the mask are automatically digitally defined. The 
image is then scanned and the density at each coordinate stored in the computer. 
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tuberculin syringe immediately before surgery and shipped 
on wet ice under sterile conditions. Human aqueous humor 
was then briefly centrifuged at low speed to remove any 
cellular debris and the aliquots of fresh aqueous humor 
from each patient were immediately used for lipid extrac- 
tion. 
2.3. Lenses 
The test and control material consisted of opaque hu- 
man lenses at different stages of cataract or normal human 
lenses. Before surgery all the lenses were studied by 
biomicroscopy and assigned to cataractous or transparent 
lenses in line with the clinical characteristics of clouding. 
Rabbit transparent lenses were obtained from freshly enu- 
cleated eyes of the Chinchilla race animals. Normal mouse 
lenses were extracted from the eyeballs by the posterior 
approach from mice of the strain C57BL or hybrids F~ 
(CBA × C57BL) resistant o cataract formation. In all 
cases the integrity of the lens capsule was preserved. The 
lenses removed were briefly rinsed in Hanks' medium for 
20-30 s and then immediately placed into a moist cham- 
ber. They were handled with the greatest care when being 
placed inside and being removed from their individual 
containers for measurements. The lenses were either used 
directly after the extraction procedure, or surgery, or at 
least 1-3 h were allowed to elapse between the dissection 
from the eye and the start of the measurement. This delay 
did not influence the results. The development of quantita- 
tive morphometric criteria for evaluation of the lens opaci- 
ties was presented by us [54,55]. All opacities were graded 
by their area and density, as judged by the degree of 
clouding (Fig. 1). The integral degree of lens clouding 
(IDLC) was estimated as the ratio between the opacity 
zone area (corresponded to maximum levels of the lens 
optical density values) and the whole lens surface area 
expressed as a percentage. This measuring procedure was 
brief (5-10 min) and did not influence the further lens 
behaviour. 
2.4. Incubation of lenses with lipid hydroperoxides 
The lenses were incubated in Hanks' balanced salt 
solution (without bicarbonate, pH 7.0) containing 7 mM 
glucose. Since most incubation media or balanced salt 
solutions comprise phosphate buffer of different molarity 
with different iron contaminations in all phosphate salts 
involved in metal-catalyzed LPO reactions, a glucose-con- 
taining medium nutritious to the lens comprising 50 mM 
Tris-HC1, 5.5 mM glucose, 4.0 mM KC1, 102.5 mM NaC1, 
1.0 mM K2HPO 4 (pH 7.2-7.4) (medium B) was used. 
Both media were adjusted to 290-300 mOsm with NaC1 
and cquilibrated with 95% air and 5% CO 2. When signifi- 
cant concentrations of oxygen scavengers or other agents 
were added, the change in osmolarity was compensated by
decreasing the amount of NaC1 used to adjust the media 
back to the required osmolarity following modification. 
The human or rabbit lenses were incubated in 3.0 ml of 
medium and the mouse lenses were placed in a cluster dish 
containing 200.0 /zl of medium/lens. The tests of lens 
integrity during incubation, to indicate that the lens is 
functioning normally, were performed as previously [56]. 
The incubations were carried out at 37°C or at room 
temperature. For incubation 10 /zl of linoleic acid 9-mono- 
hydroperoxide (LOOH), dissolved in methanol/water (9:1, 
v /v)  mixture, was suspended in the lens incubation 
medium to reach 0.5 mM concentration a d incubated with 
the lens (or without a lens, in control). When necessary, 
the lens incubation media contained the liposome suspen- 
sion (0.5 mg/ml) or phosphatidylcholine hydroperoxide 
peroxide (PLOOH) in the contents of liposomes (1 /xmole 
PLOOH/112 /xmole PL). The time of incubations varied 
from 1 to 3 h. Fixed aliquots of media (50-500 /xl) were 
taken out at different imes from the tissue cultures of 
lenses for the proper measurements of products. 
2.5. Modelling of cataract 
Experiments were carried out in 35 Chinchilla rabbits 
(70 eyes) aged 4 months weighing on average 2.5 kg. 
Cataract was induced by injection into the vitreous body of 
the rabbit eye of a suspension of liposomes prepared from 
the egg yolk phosphatidylcholine containing LPO prod- 
ucts, exactly as originally described [18]. Two months 
postinjection, rabbits were sacrificed by air embolism un- 
der general anesthesia, ccording to the resolution of the 
ARVO, Inc., on the Use of Animals in Research, and the 
ocular tissues were taken for biochemical analyses. Aque- 
ous humor was drawn off by paracentesis and then the lens 
and vitreous body were isolated. The lipids were extracted 
and the content of reduced thiols in the lenses were 
determined immediately after obtaining the material. 
2.6. Lipid extraction and quantification 
Aliquots of fresh aqueous humor from each patient or 
animal were immediately extracted into 40 vol. of chloro- 
form-methanol (2:1, v /v)  with 4-methyl-2,6-ditert-butyl- 
phenol (BHT) antioxidant addition (0.5 mg/100 ml) dur- 
ing 10 min. The obtained extract was washed according to 
the modified Folch procedure, and the chloroform layer 
was recovered and evaporated under argon [12]. Aliquots 
of the lipid residue were analysed for total phospholipid 
phosphorus and fractioned to discriminate cholesterol, free 
fatty acids and the individual spots of the polar lipids as 
described previously [45]. The techniques for phospholipid 
extraction, purification and preparation of liposomes (re- 
verse-phase evaporation technique) were reported [39,45]. 
2.7. Peroxidation reaction techniques 
Linoleic acid 9-monohydroperoxide (LOOH) was pre- 
pared by use of potassium linoleate and lipoxydase (EC 
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1.13.11.12, Type IX, potatoes) as described [57]. The 
reaction product was extracted by ether and purified by 
column chromatography on a Silica Gel L 100/250 (4 × 30 
cm) column with elution by the mixture of hexane-acetone 
(95:5). The purity of the hydroperoxide was 100 + 5% 
when estimated in methanol on the basis of its molecular 
extinction coefficient at 234 nm:2.8 × 10 4 M -1 cm -1 and 
also determined using the established iodometric technique 
[58]. Peroxidation of the phosphatidylcholine (d rived from 
egg yolk) was initiated by adding 2.5 /zM FeSO 4 and 200 
/xM ascorbate in 0.1 M Tris-HC1 buffer (pH 7.4) to the 
suspension. The incubations were performed at 37°C. The 
concentration of LPO products in the oxidized lipid sub- 
strates was measured by the reaction with thiobarbituric 
acid (TBA). The peroxidation reaction was arrested by 
adding EDTA to an end concentration f 50 /zM or by the 
addition of 2.0 ml of ice-cold 0.25 N HC1 containing 15% 
TCA. TBA (0.125%) was then added to the mixture and 
followed by boiling for 15 min. The separately utilised 
TBA assay was described previously [45]. The absorbance 
of the pink-coloured trimethine condensation product of 1 
mol malonyldialdehyde (MDA) with 2 mol TBA was 
calculated from e 535 nm MDA = 1.56 × 105 M- 1 cm- 1 
MDA, synthesized from 1,1,3,3-tetramethoxypropane by 
hydrolysis with 0.1 M HC1 for 24 h at room temperature, 
was used as standard. The TBA reaction per se was not 
affected by the components of the radical generators or 
scavengers used in the study. PLOOH was prepared by use 
of egg yolk phosphatidylcholine and the peroxidation tech- 
nique described above. The product was purified by 
preparative TLC using Silica Gel-60H (Merck) plates with 
methanol/chloroform/water (10:1.5:0.5) as a developing 
solvent. PLOOH showed an absorption maximum at 233 
nm in methanol-heptane (5:1,v/v) and a peroxide value of 
2600 = 3200 meq/kg. The content of lipid hydroperoxide 
was measured after the chloroform-methanol (2: l ,v/v) 
extraction with addition of BHT (0.5 mg/100 ml) by 
iodometric titration and measuring the absorption maxi- 
mum at 233 nm after the dissolution of a dry residue in 2.5 
ml of the methanol-heptane (5:1,v/v) mixture. This proto- 
col removes any water-soluble secondary oxidation prod- 
ucts, leaving them in the methanol-aqueous phase. The 
equalization of the extracted lipid concentrations to the 
measured phosphorus was done using the characteristic 
absorption in 206-210 nm area of the lipid sample. Accu- 
mulation of net diene conjugates corresponding to the level 
of lipid hydroperoxides was assessed from characteristic 
absorbance of diene conjugates in the UV region in a 
Shimadzu UV-260 spectrophotometer (Japan). Absorbance 
of the secondary molecular LPO products at ~ 274 nm, 
corresponding to the concentration of conjugated trienes 
and ketodienes was also measured spectrophotometrically 
from the lipid spectra [12]. An average MW of phospho- 
lipid was assumed as ~ 730 D. Lipid fluorochromes were 
determined in the same probes at 365 nm excitation and 
420- to 440-nm emission wavelengths. The fluorescence 
data were normalised to the characteristic absorption in 
206-210 nm area and to the phospholipid content. The 
spectrofluorophotometer (Shimadzu RF-540, Japan) was 
calibrated at the beginning of every working day with a 
solution of quinine-sulphate (1 /xg/ml in 0.1 N H2SO 4) 
standard, at 435 nm fluorescence emission and 365 nm 
excitation wavelengths. 
2.8. Antioxidant enzymes 
For the assays of enzyme activities, the lenses were 
weighed and homogenized in double glass distilled water. 
GPX (catalyzing reduction of organic hydroperoxide t rt- 
butyl hydroperoxide (TBHP)) activity was assayed exactly 
as described previously [56]. GSH levels in the lenses were 
determined from the reaction with 5,5'-dithiobis-2-nitro- 
benzoic acid [59]. 
2.9. Reagents 
All chemicals were of reagent grade. SOD was obtained 
from Sigma Chemical Co. (St. Louis, USA). Catalase was 
from Serva (Germany). L-Carnosine was purchased from 
Neosystem Laboratories (France). 
3. Results 
3.1. Aqueous humor 
Lipid and phospholipid contents in aqueous humor sam- 
ples obtained from human eyes were reported recently 
[45]. Typical UV absorption spectra of lipids have their 
maximum in the 206-nm regions related to absorption of 
isolated ouble bonds of hydrocarbon phospholipid chains 
(Fig. 2). Lipid extract from normal aqueous humor exhibits 
a modest shoulder of absorption at about 230 nm and a 
O.4 
Z 
'~ ~0.3  U 
0 o. 
~. o0.2 
~0.1 
• Ca~ract 
240 280 3 0 
WAVEI.ENGT H (NM)  
Fig. 2. UV absorption spectra of lipid extracts (methanol-heptane 5:1, 
v/v)  from the aqueous humor samples, obtained from human eyes: 
normal (control, lower curve) and mature cataract (upper curve). For 
details of processing procedure, see Section 2. 
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Table l 
Lipid peroxidation products in aqueous humor from the eyes of patients with cataract 
91 
Lipid peroxidation products State of the lenses/degree of lens clouding, % 
Control (n = 10) (0.0-10) Immature cataract (n = 12) (10-64) Mature cataract (n = 16) (64-100) 
I. Diene conjugates 
1. OD232/mg phospholipids 5.86 + 0.44 a 
2. OD232//OD206 0.307 4- 0.024 
3. mole/100 mole phospholipids 2.37 4- 1.14 
II. Triene conjugates, ketone and aldehyde products 
1. OD274//mg phospholipids 2.33 4- 0.13 
2. OD274//OD2o6 0.122 -t- 0.007 
III. Fluorescence products 
F1//xg phospholipids 17.2 + 6.4 
7.93 4- 0.65 b 9.48:1:0.34 ~ 
0.425 4- 0.035 d 0.518 4- 0.020 c 
5.40 4- 1.70 9.44 4- 0.89 c 
2.39 4- 0.23 2.86 5:0.40 
0.133 4- 0.012 0.163 4- 0.022 
42.0 4- 7.3 b 71.7 4- 20.2 b 
a Mean 4- S.D. (n, number of the examined samples). Significant differences with control: b p < 0.05, c p < 0.001, d p < 0.02. 
certain absorption peak around 280 nm in the UV region. 
However, lipid extract of patients with cataract usually 
exhibits the stronger absorption shoulder at 230 nm, char- 
acteristic of conjugated double bonds in the fatty acids 
(primary LPO products) and an absorption peak around 
280 nm (characteristic of ketones, secondary molecular 
LPO products) (Fig. 2, upper curve). When the level of 
secondary products not removed into the water-soluble 
phase was not significantly increased in UV absorption 
spectra of lipid extracts of aqueous humor from the 
cataractous patients (Table 1), the distinct increase of the 
contents of the end fluorescent LPO products expressed in 
terms of arbitrary fluorescence units//~g phospholipids 
(PL) was about 2.4-fold and 4.2-fold higher correspond- 
ingly for immature or mature cataracts as compared to 
normal lenses (Table 1). In the samples of aqueous humor 
aspirated from donor eyes with normal lens, one in about 
42 PL molecules contains a conjugated diene, while in 
case of immature cataract (IDLC 10-64%), the average 
amount of conjugated ienes reaches one in 19 aqueous PL 
molecules, whereas in mature cataract (IDLC 64-100%) 
this estimation averages one conjugated diene per 11 PL 
molecules. Net concentrations of primary (diene conju- 
gates, phospholipid hydroperoxides) and end (fluorescent) 
LPO products were found to be increased in aqueous 
humor of the anterior chamber in cases of cataract irre- 
spective of its genesis comparatively to donor (control) 
Table 2 
Glutathione peroxidase (substrate: organic hydroperoxide) activity of 
transparent lenses and lenses affected by cataract (M 4- m) 
Lens Lens area of Lens homogenate 
opacity a Glutathione peroxidase 
(substrate: TBHP) b 
Transparent human (n = 10) 0-10 0.514-0.04 
Immature human cataract (n = 9) 10-70 0.4044- 0.049 * * 
Mature human cataract (n = 8) 80-100 0.195 4-0.047 * 
a Ratio of area of zone of opacity to total area of lens, %; b in /xmol 
NADPH/min  per lens with tert-butyl hydroperoxide (TBHP) as the 
substrate. * P < 0.001, * * P < 0.1 compared with transparent lens. Mea- 
surements were performed at 37°C. 
eyes and in line with the maturity stage measured by 
degree of clouding (Table 1). 
3.2. Lipid hydroperoxide metabolizing activities of lenses 
In human lenses with mature cataract the activity of 
GPX (catalyzing reduction of organic and lipid hydro- 
peroxides) was sharply reduced as compared to normal 
lenses (Table 2). Kinetic studies showed that lipid hydro- 
peroxide approached saturation at concentration of ~-1 
mM, and the apparent K m value was 0.434 mM (Fig. 3). 
At the stage of mature cataract glutathione lipoperoxidase 
activity was significantly inhibited (Table 2, Fig. 3: maxi- 
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Fig. 3. Reciprocal velocity of glutathione peroxidase of normal and 
cataractous human lenses as a function of reciprocal concentration of 
tert-butylhydroperoxide. Tert-butylhydroperoxide was varied from 0.13 to 
1.52 mM with a constant glutathione concentration of 5 raM. The 
crossing point with the abscissa axis ( - K m ) -  1 indicates the K m value 
for normal and cataractous human lenses of 0.434 mM. The crossing 
points with the ordinate axis outline (Vm~x) - j  . At the concentration of 
tert-butyl hydroperoxide of 0.74 mM, the share of the occupied active 
centres of GSH peroxidase is calculated as: f~s = ([S])/([S] + K m ) = 0.63. 
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mum enzymic rate Vma x is decreased), however K m was  
unchanged. This indicates that during cataract formation a
deficiency of GPX activity occurs due to the non-competi- 
tive inhibition of enzyme. 
Human normal or cataractous lenses of different ethiol- 
ogy or degrees of opacity were exposed at 37°C for 1 h to 
linoleic acid 9-monohydroperoxide (LOOH) or PLOOH in 
the contents of 0.5 mg/ml  liposomes uspended in the lens 
incubation medium. Reducibility of LOOH or membrane 
PLOOH was studied by spectrophotometric (conjugated 
diene) or iodometric assays of the residual LOOH(PLOOH) 
levels during the incubation of lenses (or without a lens in 
a background study), and MDA levels were determined as 
TBA-reactive substances (TBARS). Results of a typical 
experiment are shown in Fig. 4a,b. The starting level of 
LOOH in the incubation medium was of 0.5 mM and 1 
/xmol PLOOH per 112 /xmol of membrane PL. Incuba- 
tions with normal human, immature or mature cataractous 
lenses for 1 h at 37°C caused a decrease of total liberated 
fatty acid hydroperoxide (LOOH), correspondingly, to 310 
___ 50 nmol/lens (mean___ S.E.M., n = 10) at IDLC of 
0-10% (ages 17-64 years); to 192 + 85 nmol/lens (n = 4) 
at IDLC of 10-65% (ages 60-89 years) and to 85 + 70 
nmol/lens (n =4)  at IDLC of 66-100% (ages 71-86 
years) in 1.0 ml volume of incubation medium. Within the 
same time interval of incubation and temperature, human 
transparent or cataractous lenses showed little or no reduc- 
tion of the liposome membrane PLOOH (Fig. 4b) but, 
instead, the assay system detected more absorbance changes 
of conjugated diene, iodometric and TBARS measure- 
ments in incubations of transparent or immature catarac- 
tous human lenses, indicating the PLOOH-dependent prop- 
agation of lipid hydroperoxides and that the assay system 
was fully operational. Incubation with 0.5 mM EDTA 
produced no net reducing effect on the LOOH(PLOOH) 
level over that observed in control incubations (LOOH or 
PLOOH alone). The reducing agent 10 mM NaBH 4 showed 
the significant reactivity (62%) for the measurable LOOH 
reduction relative to the background ecay. 
Human lenses with different degrees of opacity and 
transparent rabbit or mice lenses were incubated in the 
tissue medium B containing 0.5 mg/ml  liposome suspen- 
sion as the oxidation substrate for 3 h at room temperature, 
and the kinetics of LPO reaction were estimated by mea- 
suring MDA, liposomal-conjugated dienes and trienes 
making appropriate corrections for liposome autooxidation 
(Fig. 4c-e). In the absence of the lens, virtually no oxida- 
tion of liposomes took place during 180 min (Fig. 4c-e, 
curve 5). In the presence of the lens, a marked increase in 
concentration of different molecular LPO products was 
demonstrated for the proper time of incubation. The rate of 
MDA accumulation during the first 30 min of incubation 
was significantly higher in the presence of transparent 
human lenses (and also of lenses at the initial stage of 
cataract) than in the presence of lenses with a mature 
cataract and the final MDA level within 3 h of incubation 
was 2.5- to 4.5-fold higher for transparent lens than for the 
lens with a ripe cataract, integrally indicating that human 
mature cataractous lenses peroxidized liposomes less than 
the transparent lenses. The level of MDA accumulation 
after incubation for 3 h of rabbit lenses was 3.5- and 
5.3-fold higher than of normal human or mouse lenses. 
The larger normal lenses (rabbit or human) are metaboli- 
cally active and generate the reactive oxygen species and 
Fig. 4. Reactivity of hydroperoxides with human normal and catamctous lenses measured by iodometric, conjugated iene and TBARS assays. The lenses 
were treated with either (a) 0.5 mM linoleic acid 9-monohydroperoxide (LOOH) or (b) membrane phospholipid hydroperoxide (PLOOH) (1 /xmol PLOOH 
per 112 /.tmol of membrane phospholipid in 0.5 mg/ml liposomes) suspended in the incubation medium of the lens (Hanks' balanced salt solution, pH 
7.0) and incubated for 1 h at 37°C. At the end of incubation, samples were aspirated and the content of lipid hydropero×ide was determined (see Section 2). 
Initial levels of peroxide in the reaction mixture and at the end of incubation are shown. (a): A, background incubation of LOOH without lens; B, LOOH 
incubation with transparent human lens (IDLC 0-10%, ages 17-64 years, n = 10); C, LOOH incubation with immature cataractous human lens (IDLC 
10-65%, ages 60-89 years, n = 4): D, LOOH incubation with mature human cataract (IDLC 66-100%, ages 71-86 years, n = 4). Significant differences 
from transparent lens * * P < 0.05 and from the background incubation * P < 0.01 are indicated. (b): A, background incubation of PLOOH in liposomes 
without lens; B, PLOOH with transparent human lens (IDLC 0-10%, ages 20-45 years, n = 3); C, PLOOH incubation with immature human cataractous 
lens (IDLC 10-65%, ages 55-70 years, n = 3); D, PLOOH incubation with mature human cataractous lens (IDLC 66-100%, ages 76-89 years, n = 3). 
Significant difference from the initial level of PLOOH in the reaction mixture * * P < 0.05 is indicated. Normal lenses obtained from the cases of 
incidental death and cardiovascular shock were included in the group of transparent lenses. The lenses obtained uring surgery from the patients with senile 
(9 lenses) and complicated (5 lenses) cataracts were included in the C and D groups on the basis of IDLC measurements (see Section 2). Data columns 
shown with error bars are means ± S.E.M. of 3-10 lenses. (c-e): The accumulation of lipid peroxides: TBA-reactive substances (c), conjugated diene (d); 
triene conjugates, ketone and aldehyde products (274 nm absorbing material) (e) in the liposomes (0.5 mg/ml) incubated alone (control) or in the 
lens-containing medium B at room temperature for 3 h. Samples were taken at zero time and at varying time intervals as indicated in the figures. The 
above fixed aliquots of samples (50-500 /zl) were directly used for the measurement of TBA-reactive substances (for details, see Section 2). Also, a 
similar amount of incubated sample was partitioned through chloroform as described in the lipid extraction procedure and after dissolution in 2-3 ml of 
methanol-heptane mixture (5:1, v /v)  was used for detection of conjugated iene and triene conjugate/ketones (274 nm absorbing material). (1) 
Transparent rabbit lenses (IDLC 0-8%), Mean ± S.E.M., n = 5; (2) transparent human lenses (IDLC 0-10%), n = 4, initial cataract (IDLC 10-40%), 
n = 3; (3) human mature cataractous lenses (1DLC 64-100%), n = 5; (4) six normal mice lenses (IDLC 0-10%), n = 3; (5) (control) liposomes, n = 5. 
Experimental details are given in the text. (f): Effect of various oxygen radical scavengers on lipid peroxide formation in liposomes added to the incubation 
medium of the normal rabbit lens (IDLC 0-8%). In a total vol of 3.0 ml the incubation mixture of the lens contained medium B, 0.5 mg/ml liposome 
suspension and the appropriate concentrations of scavenger as indicated. Mean values for the MDA concentrations are given for a representative 
experiment, with the error bars indicating the standard eviation obtained for the group of 3-5 lenses. 
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Fig. 4 (continued)• 
lipid peroxides more rapidly than cataractous lenses with 
the exhausted pool of reductants or tiny mouse lenses [45]. 
Fig. 4c and 4f document in some cases a small decrease in 
the liposomal MDA concentration after incubation for 2 h. 
This might be connected with MDA utilization by the lens 
itself (interaction of MDA with amino group, or its lower- 
ing by lenticular aldehyde dehydrogenase [60]). A consid- 
erable reduction of the accumulation rate of the liposomal 
LPO products was found after the addition of catalase (900 
U/sample) (Fig. 4f, curve 3). This suggests a role of 
H202 in promotion of LPO by the lens. Addition of SOD 
(114 U/sample) to the incubation medium of the lens led 
to a marked reduction of the liposomal MDA level (Fig. 
4f, curve 4), suggesting the ability of the lens to generate 
0 2 in the surrounding medium. Addition of the ADP-Fe 
complex to the incubation medium of the lens decreased 
accumulation of TBA-reactive material in liposomes by 
33-50%, indicating a decomposition of the accumulated 
TBA-reactive material. The LPO is resulted from free-radi- 
cal oxidation reactions induced by active oxygen forms 
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with participation of transition metal ions in the free 
catalytically active state. This is supported by the virtually 
total inhibition of TBA-reactivity in the liposomes after the 
addition of the chelating agent 1 mM EDTA eliminating 
the free and accessible metal ions from the peroxidizing 
system (Fig. 4f, curve 5). In the presence of 5 mM 
L-carnosine in the rabbit lens/ l iposome-conta in ing 
medium, a decrease in the TBA-reactivity by approx. 25% 
for 2 h of incubation was revealed (Fig. 4f, curve 7). Since 
the reactivity of L-carnosine with O~, H 202 or hypochlor- 
ous acid at biologically significant rates was neglected as 
well as its binding ability with iron ions excluded [61], the 
specific inhibitory effect of L-carnosine in the incubation 
system detects OH or lipid peroxy radicals (LOO)  gener- 
ated in the medium surrounding the lens in organ culture 
[62]. 
3.3. Induction of cataract by phospholipid hydroperoxides 
The introduction into the vitreous body of the rabbit eye 
of a l iposome suspension in an amount of 0.4 mg (content 
of MDA 2.0 nmol / tzmol  PL) induced the development of 
typical posterior subcapsular cataract within 24 h. The 
anterior cortex and the nucleus of the lens remained trans- 
parent but clouding was noted in the region of the poste- 
rior pole of the lens and in the vitreous body. Injection into 
the vitreous body of the rabbit eye of the same quantity of 
more oxidized liposomes (22.2 nmol MDA/ /~mol  PL) 
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Fig. 5. Type of clouding on modelling cataract by liposomes (0.4 mg phospholipids) within 24 h (10 × ). Injection into vitreous body of (A) oxidized 
phospholipids (22.2 nmole MDA//.~mol phospholipids); (B) liposomes prepared from fl-oleoyl-y-palmitoyl-L-a-phosphatidylcholine. Photographs 
obtained with an ZEISS SL-30 photoslit lamp. (C) Spectra of excitation with A n = 438 nm (a) and emission with Aexcit = 365 nm (b) of the fluorescence 
of lipid extracts (methanol/heptane, 5:1) from the lenses after introduction i to the eye of saturated liposomes (1) and liposomes from oxidized 
phospholipids (2). (D) Level of GSH in lens as a function of the accumulation f LPO products, F1 is level of fluorescing LPO products in lens. 
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Table 3 
Intensity of fluorescence (relative units) of lipid peroxidation products in eye 
l iposomes (~excit. = 365 nm; hemi~ =438 nm) 
tissues on modelling cataract by non-oxidized, oxidized and saturated 
Tissue Norm Non-oxidized liposomes 
2.0 nmol MDA//xmol of 
phospholipids 
Oxidized liposomes: 
22.2 nmol MDA//xmol of 
phospholipids 
Saturated liposomes: 
1.2 nmol MDA//xmol of 
phospholipids 
Lens 96 + 20 150 __+ 20 170 + 30 100 _ 10 
(n = 10) (n = 7) (n = 10) (n = 6) 
Vitreous body 80 ± 30 300 + 100 173 + 40 80 + 10 
Aqueous humor 130 + 30 230 + 50 240 + 14 170 + 8 
The data obtained on introducing 0.4 mg phospholipids into the eye are presented. The concentration f the material in the specimens was equalized for the 
concentration f lipids (calculated from the characteristic absorption ofthe lipid extract at 206 nm). The relative fluorescence of quinine sulfate (1 p.M in 
0.1 M H2SO 4) standard was 375 units at emissioa 460 nm on excitation at 365 nm. The measurements were made on day 60 after liposome injection. 
Table 4 
The content of total and non-protein thiols in rabbit lenses on modelling cataract by non-oxidized, oxidized and saturated liposomes 
Liposomes C = 0.4 mg C = 1.5 mg 
n C o GSH n C O GSH 
Non-oxidized 7 2.92 + 0.34 450 ___ 116 8 2.99 + 0.37 251 + 75 
Oxidized 10 2.96 + 0.24 403 + 63 8 3.10 + 0.47 121 + 52 
Saturated 6 3.2 + 0.5 520 _ 71 3 3.1 + 0.6 500 + 102 
Control 10 4.1 + 0.4 705 +_ 106 
The mean molecular weight of protein taken as equal to 20000. 
C, content of phospholipids; Co, the total content of thiols (/zmol//xmol protein); GSH, reduced glutathione (nmol/tzmol initial protein). The majority of 
the reduced non-protein-bound thiols is represented as reduced glutathione. 
(Fig. 5A) and also of a higher dose of l iposomes contain- 
ing LPO products led to more marked clouding of the lens, 
which, however, was localized to a high degree in the 
middle cortex. The introduction into the vitreous in the 
control series of solvent (in which the l iposome suspension 
was prepared) contained 2 .5 /zM Fe 2+, 200/~M ascorbate, 
50 /zM EDTA and also l iposomes containing 0.1 mg 
phospholipids did not cause appreciable clouding of the 
lens. Injection into the rabbit vitreous body of 0.4-1.5 mg 
/3-oleoyl- 7-palmitoyl-L-ot-phosphatidylcholine l iposomes 
prepared from saturated phospholipids (level 1.2 nmol 
MDA/ /zmol  PL) did not lead to clouding of the lens (11 
eyes examined) (Fig. 5B). However, in some cases, the 
presence of single cells of inflammation in the vitreous 
body was noted. Observation for 2 months of the rabbits 
with cataract did not reveal its regression. The induction of 
posterior subcapsular cataract was accompanied by the 
accumulation of fluorescing LPO products in the vitreous 
body, aqueous humor and lens (Table 3, Fig. 5C). On day 
60, the level of these products was maximum in the 
vitreous body in the case of introduction of non-oxidized 
(2.0 nmol MDA/ /xmol  PL) but prepared from unsaturated 
(potentially auto-oxidized) phospholipids and the aqueous 
humor and lens on injection of already highly oxidized 
(22.2 nmol MDA/ /zmol  PL) liposomes. Apparently this 
reflects the diffusion of the polar secondary LPO products 
from the vitreous body towards the lens. The clouding of 
the lens was accompanied by a regular drop in the concen- 
tration of GSH with a concomitant accumulation of fluo- 
rescing LPO products (Table 4, Fig. 5D). This confirms 
the hypothesis that LPO products induce oxidation of the 
cell thiols leading to clouding of the lens. However, the 
insignificant fall in the concentration of the total thiols in 
lens (Table 4) indicates that in this type of posterior 
subcapsular cataract he main cause of polymerization of 
the crystallins is their interaction with the intermediate 
LPO products-bifunctional compounds of the dialdehyde 
type. 
4. Discussion 
The primary molecular LPO products, i.e., phospholipid 
hydroperoxides and their in vivo indicator, diene conju- 
gate, represent the major change in the lipid composition 
of aqueous humor during cataract formation. At the stages 
of ripe cataract, end fluorescent LPO products are dis- 
tinctly detected. Crystalline lens is well equipped with 
antioxidant defences showing some specificity in their 
action. Primary defence prevents the initiating reactions of 
LPO and is achieved by the enzyme scavengers of reactive 
oxygen species, e.g., SOD, catalase and GPX utilizing 
H202; chemical antioxidants, e.g., a-tocopherol, r -caro-  
tene, ascorbate and GSH; structural antioxidants, e.g., 
cholesterol and membrane protein; transition metal-seques- 
tering proteins including aqueous and plasma coeruloplas- 
min and transferrin. A second mode of the lens protection 
involves enzymatic removal of l ipid-derived hydro- 
peroxide intermediates. These reactions are typically cat- 
alyzed by Se-dependent GPX of the lens in addition to 
M.A. BabizhayeL, / Biochinica et Biophysica Acta 1315 (1996) 87- 99 97 
primary lines of defence that involve iron inactivation or 
oxyradical and H202 scavenging. Mature human catarac- 
tous lenses showed the decreased activities of GPX (reduc- 
ing organic hydroperoxides, including hydroperoxides of
lipids), glutathione reductase, SOD, but no signs of defi- 
ciency in activities of catalase or GPX (utilizing H202) 
(this study, and Ref. [56]). The larger sizes of a lipid 
hydroperoxide molecule, its highly hydrophobic haracter 
and lower solubility in aqueous ystem than of the H202 
molecule are responsible for different accessibility of the 
hydroperoxide substrates for Se-dependent lens GPX. Ki- 
netic studies revealed that for the single lens, GPX activity 
towards H202 (GSH-H202 oxidoreductase, EC 1.11.1.9) 
was significantly higher than GPX activity towards TBHP 
[56]. The reaction rate was too rapid with 1 mM H202 to 
be compared with equimolar concentration of TBHP. The 
reaction rate with 0.074 mM H20 2 was similar to that with 
0.74 mM TBHP and considerably more rapid than 0.74 
mM concentration of this substrate. The apparent K m for 
H202 was 0.045 raM, an order of magnitude lower than 
those for TBHP. So lens GPX has a greater affinity for the 
natural substrate H20~ " and is able to remove the cytosolic 
hydroperoxides. The lipid peroxidase activity of the lens is 
critical in the prevention of LPO in cell membranes and 
can play a role in the maintenance of its clarity. Exposure 
of transparent human lenses to LOOH (0.5 mM) resulted 
in significant decrease (62%) in the concentration of 
hydroperoxide in the culture medium after 1 h of incuba- 
tion. Immature senile or complicated cataractous lenses 
detoxified correspondingly, 62% and 91% of the LOOH or 
H202 amounts reduced by transparent human lenses upon 
the hydroperoxide has been pulsed in the incubation 
medium. Thus the peroxidase ability of lenses is not 
diminished significantly in early cataracts (see also Ref. 
[56]). Mature human cataractous lenses cause a 17% de- 
crease of total LOOH per lens when incubated for 1 h at 
37°C. This stage (IDLC 66-100%) of cataract differs 
significantly in the lower GSH lipoperoxidase activity and 
decreased GSH level in the lens (this study and Ref. [63]. 
The level of lipid hydroperoxide in the medium was 
decreased by incubation with lenses due to the fact that the 
lipid hydroperoxide was taken up by the lens or was 
scavenged by factors (enzyme and/or non-enzyme anti- 
oxidants) released from the lenses. GPX is known to 
catalyze the reduction of a wide range of hydroperoxides 
including hydroperoxides of free fatty acids. However, the 
lens lipid peroxidase showed failure to decrease the resid- 
ual membrane-bound PLOOH level during the incubation 
of normal or cataractous lenses for 1 h at 37°C. The 
negligible loss of peroxide incorporated in the natural 
membranes (liposomes) bathed in an aqueous environment 
of lenses is anticipated ue to steric inaccessibility of the 
non-stripped from the lipid bilayer hydroperoxide sub- 
strates of a heterogeneous population, the composition of 
which is dependent on the nature of unsaturated fatty acyl 
groups in the sn-2 position. When the intact human trans- 
parent and cataractous lenses or normal mouse and rabbit 
lenses were incubated with liposomes in organ culture, the 
level of liposomal hydroperoxides was significantly (2.5- 
4.5-fold) higher after 3 h of incubation of the transparent 
lenses (or the lenses at initial stage of cataract) at room 
temperature than after the proper time of incubation of 
human mature cataractous lenses and no oxidation of prior 
untreated liposomes was detected in the absence of the 
lens. Metabolic devices in the normal lens are thus ad- 
justed not just with destruction of oxidants, but rather 
specialized reactions also exist for the production of free 
radicals. It would be anticipated that the mature catarac- 
tous lenses maintain more peroxides in aqueous humor and 
the lens tissues [12] because of their reduced etoxification 
potential, e.g., reduced ability to detoxify HzO z due to 
depletion of GSH, decreased activities of GSH reductase. 
SOD and an impairment of GPX (catalyzing reduction of 
organic/lipid hydroperoxides) [45]. LPO in the lens incu- 
bation system was decreased in the presence of free radical 
scavengers and enzymes that degrade H202 (EDTA, SOD. 
catalase, L-camosine and chelated iron). The most effective 
agent was EDTA which chelates the free metal cations 
required to generate O~ radicals that initiate the free 
radical process culminating in LPO. The mechanism of 
metal-catalysed oxidation reactions of the lens reductants 
(GSH, ascorbate, lens crystallins containing SH groups) 
was proposed as a basic for release of free radicals or lipid 
hydroperoxides in the lens medium and the rates and final 
levels of oxidants formation by lenses were found in- 
versely dependent to their integral degrees of clouding 
[45]. 
Since lipoproteins are present in aqueous humor, a 
possibility cannot be ruled out that their lipid moiety may 
undergo xidation in systemic diseases (chronic renal fail- 
ure, anemia, diabetes, atherosclerosis, nflammation, reti- 
nal diseases) and ageing [64] and that phospholipid perox- 
ides can contribute to the oxidative insult triggering the 
onset risk of cataract. In the anterior segment of the eye, 
the iris-ciliary body is the source of phospholipases A 2, C 
and arachidonic acid contributing to protective capacity to 
synthesize prostaglandins, other cyclooxygenase and 
lipoxygenase products in ocular fluids and tissues includ- 
ing the lens cells [65-68]. The activity of intrinsic 
phospholipase A 2, able to attack both non-oxidized and 
oxidized phospholipids in subcellular fraction of the lens, 
arranges lipid environment in the lens membrane increas- 
ing the cholesterol/phospholipid ratio [69] and hydrolyz- 
ing phospholipid hydroperoxides for accessible reduction 
with GPX. Phospholipid peroxidation products are a signif- 
icant cataract-forming factor, since their entrance into the 
vitreous body of the eye induces the development of 
posterior subcapsular cataract with the concomitant fall in 
the concentration of GSH in the lens. Such mechanism of 
cataract induction was proposed on degeneration of retina 
[18]. 
The hydrophobicity of phospholipid amphiphilic 
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molecules i determined by their hydrocarbon tails, so their 
shortening by oxidative destruction of hydroperoxides or
their chemical modification leading to the appearance of 
polar (hydroperoxide, carbonile) groups in fatty acyl, in- 
evitably effects their hydrophilic-hydrophobic alance. 
Such modified molecules acquire properties of detergents 
similar to lisophospholipids forming under the action of 
phospholipase A 2. As a result of LPO, phospholipids 
modified with oxygen appear in lenticular fibre mem- 
branes able to increase the plasma membrane hydrophilic- 
ity and to impair lipid-lipid and protein-lipid interactions. 
The structural modifications of phospholipids of the lens 
fibre cell membranes atthe carbonyl and phosphate-oxygen 
sites have been recently demonstrated upon metal oxida- 
tion using vibrational Fourier transform IR spectroscopy 
[70]. These effects form a basis of membrane fragmenta- 
tion, interdigitations and foldings in the opaque and aged 
regions of the lens matter [12]. Leakage of water-soluble 
lens proteins (3,- and a-crystallines) into both aqueous and 
vitreous humors might be expected to occur [71-74] as a 
result of hydroperoxide, lipid peroxy radical and free 
radical oxygen toxicity to the lens in senile and compli- 
cated cataracts. The development of cataracts might be due 
to a disturbance of the lens cation permeability through 
cell membranes caused by phospholipid hydroperoxides. 
The lens fiber cell membrane is the site of oxidation-in- 
duced precipitation of cytoplasmic proteins, eventually 
producing aggregates of proteins around membrane mi- 
celles and fragments that serve as scattering centers. 
Cross-linking of biomolecules by the reaction of the car- 
bonyl groups of MDA and amino groups of amino acids, 
proteins, nucleic acids and their bases, and phospholipids 
produces lipofuscins, fluorescent Schiff-base conjugates 
resulting in formation of high molecular weight aggregates 
chronically accumulated in cataracts and increased in ripe 
cataracts as well as inactivating enzymes in the lens 
[11,38,21]. It is apparent from the findings that 
membrane-bound phospholipid hydroperoxides escape 
detoxification by the lens enzymatic reduction. The lens 
cells containing these species would still be vulnerable to 
peroxidative attack which trigger the PLOOH-dependent 
chain propagation of LPO and other damages in membrane 
(lipid and protein alterations). Since LPO is clinically 
important in many of the pathological effects and ageing, 
new therapeutic modalities should treat he incessant inflic- 
tion of damage to the lens cells and biomolecules by 
reactive lipid peroxides and oxygen species and 'refashion' 
the affected lens membranes in the lack of important 
metabolic 'detoxification' of phospholipid peroxides. 
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